Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Mycobacterium avium subsp. paratuberculosis
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Crohn's disease=== MAP is recognized as a multi-host mycobacterial pathogen with a proven specific ability to initiate and maintain systemic infection and [[chronic inflammation]] of the intestine of a range of histopathological types in many animal species, including primates.<ref name="Johnes">{{cite web |title=Johne's Information Center |url=http://www.johnes.org/ |access-date=2008-06-13}}</ref> MAP has been found in larger numbers within the intestines of Crohn's disease patients<ref name="pmid16443282">{{cite journal|year=1992|title=Mycobacterium paratuberculosis DNA in Crohn's disease tissue|journal=Gut|volume=33|issue=7|pages=890β6|doi=10.1136/gut.33.7.890|pmc=1379400|pmid=1644328|vauthors=Sanderson JD, Moss MT, Tizard ML, Hermon-Taylor J}}</ref> and in significant amount of [[irritable bowel syndrome]] patients<ref>{{Cite journal|last1=Scanu|first1=Antonio M.|last2=Bull|first2=Tim J.|last3=Cannas|first3=Sara|last4=Sanderson|first4=Jeremy D.|last5=Sechi|first5=Leonardo A.|last6=Dettori|first6=Giuseppe|last7=Zanetti|first7=Stefania|last8=Hermon-Taylor|first8=John|date=December 2007|title=Mycobacterium avium Subspecies paratuberculosis Infection in Cases of Irritable Bowel Syndrome and Comparison with Crohn's Disease and Johne's Disease: Common Neural and Immune Pathogenicities|journal=Journal of Clinical Microbiology|volume=45|issue=12|pages=3883β3890|doi=10.1128/JCM.01371-07|issn=0095-1137|pmc=2168579|pmid=17913930|quote=Mycobacterium avium subsp. paratuberculosis was detected in 15 of 20 (75%) patients with irritable bowel syndrome, 3 of 20 (15%) healthy controls, and 20 of 23 (87%) people with Crohn's disease}}</ref> compared to those with [[ulcerative colitis]] or otherwise healthy controls. One study concluded that MAP "may act as a causative agent, have a role in the context of secondary infection, which may exacerbate the disease, or represent non-pathogenic colonisation."<ref name="Feller"/> The [[Crohns MAP Vaccine]] is an experimental vaccine based on this hypothesis.<ref>{{Cite web|title=The Crohn's Vaccine|url=https://crohnsmapvaccine.com/vaccine/|access-date=2021-06-19|website=Crohn's MAP Vaccine|language=en-GB}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)